By Turna Ray 

Cepheid received 510(k) clearance from the US Food & Drug Administration this week for its Xpert vanA, a test that gauges the presence of an antimicrobial resistance gene commonly linked to vancomycin-resistant Enterococci (VRE), a serious healthcare-associated infection.

The test runs on Cepheid's GeneXpert RT-PCR system The FDA-cleared Xpert vanA test will be commercially available for shipment to customers this month.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.